Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Danaher

Is It Too Late to Chase Masimo Stock on Major Danaher News?

Masimo stock rallies as Danaher announces plans of buying the health tech firm for $180 a share in cash. But is there any further upside left in MASI shares?

Barchart

Stocks Recover on Strength in Apple and Airline Stocks

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.10%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.07%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.13%. March E-mini S&P futures (ESH26 ) rose +0.12%, and March E-mini Nasdaq futures...

Barchart

Stocks Fall as AI Concerns Dampen Market Sentiment

The S&P 500 Index ($SPX ) (SPY ) today is down -0.57%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.10%. March E-mini S&P futures (ESH26 ) are down -0.62%, and March E-mini Nasdaq futures...

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Danaher Stock: Is DHR Underperforming the Healthcare Sector?

Despite Danaher’s underperformance relative to the healthcare sector, Wall Street analysts remain strongly optimistic about the stock’s prospects.

Barchart

These Analysts Increase Their Forecasts On Danaher Following Upbeat Q3 Earnings

Danaher Corporation (NYSE:DHR) reported better-than-expected third-quarter financial results on Tuesday.

Benzinga

Danaher Reports Strong Q3 Earnings, Shares Move Higher

Danaher Corporation (NYSE:DHR) shares are rising Tuesday after the company reported better-than-expected third-quarter financial results.

Benzinga

Earnings Preview: What To Expect From Danaher's Report

Healthcare giant Danaher is gearing up to announce its Q3 results in the upcoming week, and analysts expect its earnings growth to remain mostly flat.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Is Danaher Stock Underperforming the Dow?

Although Danaher has lagged behind the Dow over the past year, analysts remain bullish about the stock’s prospects.

Barchart

Danaher Lifts 2025 Earnings Outlook Amid Biotech Growth, Cost Discipline

Danaher Corp (NYSE:DHR) on Tuesday reported second-quarter 2025 sales of $5.94 billion, up 3.5% year-over-year, beating the consensus of $5.84 billion.

Benzinga

S&P Futures Muted With Focus on Earnings and Trade Deals

September S&P 500 E-Mini futures (ESU25) are trending down -0.04% this morning as investors brace for a raft of corporate earnings reports and continue to keep a close eye on any trade developments between the U.S. and key trading partners as the August 1st deadline approaches.

Barchart

Jim Cramer 'Worried' About Workday, Calls Applied Digital 'A Good Spec'

On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended staying away from Workday, Inc. (NASDAQ:WDAY). “I'm worried. There's a lot of companies coming for Workday, and I don't like that,” he added.

Benzinga

Is Danaher Stock Outperforming the Nasdaq?

Danaher has notably underperformed the Nasdaq composite over the past year, yet analysts remain highly optimistic about the stock’s long-term prospects.

Barchart

Stocks Rebound Sharply on Trade Deal Optimism

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +2.51%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +2.66%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +2.63%. June E-mini S&P futures (ESM25 ) are up +2.52%, and June E-mini Nasdaq futures...

Barchart

Stocks Climb on Trade Deal Optimism and Strong Q1 Earnings

The S&P 500 Index ($SPX ) (SPY ) today is up +1.82%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.91%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +2.13%. June E-mini S&P futures (ESM25 ) are up +1.98%, and June E-mini Nasdaq futures...

Barchart

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Danaher's Q1 2025 Earnings: What to Expect

Danaher is all set to release its fiscal first-quarter earnings later this month, and analysts project a double-digit profit decline.

Barchart

Enovis Hits Another 52-Week Low. Here’s Why It’s a Contrarian Buy.

The orthopedic medical device company hit its 41st 52-week low. The stock looks unnecessarily beaten down, off 41% over the past 12 months and 62% from its all-time high in November 2021, making it a contrarian buy.

Barchart

Is Danaher Stock Underperforming the S&P 500?

Although Danaher has underperformed the S&P 500 Index over the past year, analysts remain bullish about the stock’s prospects.

MarketBeat

3 Stocks Offering Strong Value and Stability

These stocks may be undervalued based on recent price activity, new partnerships, or disappointing earnings that mask strong underlying performance.

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Are Wall Street Analysts Bullish on Danaher Stock?

Healthcare giant Danaher has significantly underperformed the broader market over the past year, yet analysts remain strongly bullish on the stock’s longer-term prospects.

Barchart

Stocks Fall on Hawkish Fed Pause

The S&P 500 Index ($SPX ) (SPY ) Wednesday closed down -0.47%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.31%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.24%. March E-mini S&P futures (ESH25 ) are down by -0.53%, and March E-mini Nasdaq...

Barchart

Stocks Slip as FOMC Expected to Pause Rate Cuts

The S&P 500 Index ($SPX ) (SPY ) today is down -0.28%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.16%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.33%. March E-mini S&P futures (ESH25 ) are down by -0.29%, and March E-mini Nasdaq...

Barchart

Danaher Earnings Preview: What to Expect

Healthcare giant Danaher is set to unveil its fourth-quarter earnings later this month and analysts expect a modest single-digit growth in earnings.

Barchart

How Is Danaher’s Stock Performance Compared to Medical Devices Stocks

Danaher has underperformed the Medical Devices industry, though Wall Street analysts remain strongly optimistic about its future prospects.

Barchart

What Are Wall Street Analysts' Target Price for Danaher Stock?

Although Danaher has underperformed relative to the broader market over the past year, Wall Street analysts maintain a bullish outlook about the stock’s prospects.

Barchart

What You Need to Know Ahead of Danaher's Earnings Release

With Danaher gearing up to release its third-quarter earnings later this month, analysts expect double-digit earnings decline.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

International Monetary Fund

the Wall Street Journal

1,097 stories

Warner Bros Discovery

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.